Assessment of the potential allergenicity of genetically-engineered food crops

An extensive safety assessment process exists for genetically-engineered (GE) crops. The assessment includes an evaluation of the introduced protein as well as the crop containing the protein with the goal of demonstrating the GE crop is “as-safe-as” non-GE crops in the food supply. One of the evalu...

Full description

Bibliographic Details
Main Author: Gregory S. Ladics
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Journal of Immunotoxicology
Subjects:
ige
Online Access:http://dx.doi.org/10.1080/1547691X.2018.1533904
id doaj-72894d0a4d9248e3ab1391ae5fb9ec70
record_format Article
spelling doaj-72894d0a4d9248e3ab1391ae5fb9ec702020-11-25T01:58:23ZengTaylor & Francis GroupJournal of Immunotoxicology1547-691X1547-69012019-01-01161435310.1080/1547691X.2018.15339041533904Assessment of the potential allergenicity of genetically-engineered food cropsGregory S. Ladics0DuPont CompanyAn extensive safety assessment process exists for genetically-engineered (GE) crops. The assessment includes an evaluation of the introduced protein as well as the crop containing the protein with the goal of demonstrating the GE crop is “as-safe-as” non-GE crops in the food supply. One of the evaluations for GE crops is to assess the expressed protein for allergenic potential. Currently, no single factor is recognized as a predictor for protein allergenicity. Therefore, a weight-of-the-evidence approach, which accounts for a variety of factors and approaches for an overall assessment of allergenic potential, is conducted. This assessment includes an evaluation of the history of exposure and safety of the gene(s) source; protein structure (e.g. amino acid sequence identity to human allergens); stability of the protein to pepsin digestion in vitro; heat stability of the protein; glycosylation status; and when appropriate, specific IgE binding studies with sera from relevant clinically allergic subjects. Since GE crops were first commercialized over 20 years ago, there is no proof that the introduced novel protein(s) in any commercialized GE food crop has caused food allergy.http://dx.doi.org/10.1080/1547691X.2018.1533904genetically-engineered cropsagricultural biotechnologysafety assessmentweight-of-the-evidenceallergenicityprotein allergyfood allergyigeceliac disease
collection DOAJ
language English
format Article
sources DOAJ
author Gregory S. Ladics
spellingShingle Gregory S. Ladics
Assessment of the potential allergenicity of genetically-engineered food crops
Journal of Immunotoxicology
genetically-engineered crops
agricultural biotechnology
safety assessment
weight-of-the-evidence
allergenicity
protein allergy
food allergy
ige
celiac disease
author_facet Gregory S. Ladics
author_sort Gregory S. Ladics
title Assessment of the potential allergenicity of genetically-engineered food crops
title_short Assessment of the potential allergenicity of genetically-engineered food crops
title_full Assessment of the potential allergenicity of genetically-engineered food crops
title_fullStr Assessment of the potential allergenicity of genetically-engineered food crops
title_full_unstemmed Assessment of the potential allergenicity of genetically-engineered food crops
title_sort assessment of the potential allergenicity of genetically-engineered food crops
publisher Taylor & Francis Group
series Journal of Immunotoxicology
issn 1547-691X
1547-6901
publishDate 2019-01-01
description An extensive safety assessment process exists for genetically-engineered (GE) crops. The assessment includes an evaluation of the introduced protein as well as the crop containing the protein with the goal of demonstrating the GE crop is “as-safe-as” non-GE crops in the food supply. One of the evaluations for GE crops is to assess the expressed protein for allergenic potential. Currently, no single factor is recognized as a predictor for protein allergenicity. Therefore, a weight-of-the-evidence approach, which accounts for a variety of factors and approaches for an overall assessment of allergenic potential, is conducted. This assessment includes an evaluation of the history of exposure and safety of the gene(s) source; protein structure (e.g. amino acid sequence identity to human allergens); stability of the protein to pepsin digestion in vitro; heat stability of the protein; glycosylation status; and when appropriate, specific IgE binding studies with sera from relevant clinically allergic subjects. Since GE crops were first commercialized over 20 years ago, there is no proof that the introduced novel protein(s) in any commercialized GE food crop has caused food allergy.
topic genetically-engineered crops
agricultural biotechnology
safety assessment
weight-of-the-evidence
allergenicity
protein allergy
food allergy
ige
celiac disease
url http://dx.doi.org/10.1080/1547691X.2018.1533904
work_keys_str_mv AT gregorysladics assessmentofthepotentialallergenicityofgeneticallyengineeredfoodcrops
_version_ 1724969997777764352